GlassScriptPhysician profile
Brielle Reyes
NPI 1811502669
$4,414.63
in general payments reported to CMS, 2019-2025
22 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $266 · 2023: $694 · 2024: $2,871 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,740 · Travel and Lodging: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,739.86 |
| Travel and Lodging | $1,252.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,313.30 | 2021-2025 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Esperion Therapeutics, INC. | $241.37 | 2023-2025 | Nexletol, Nexlizet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.82 | 2023-2025 | Jardiance |
| Medtronic, INC. | $220.12 | 2021-2025 | Corevalve Evolut R |
| Irhythm Technologies, INC. | $188.40 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $179.34 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $177.27 | 2022-2025 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.63 | 2023-2025 | Lifevest |
| Biosense Webster, INC. | $113.75 | 2023 | Qdot Micro Catheter, Carto 3 |
| Amgen INC. | $101.34 | 2023-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $76.05 | 2024-2025 | Verquvo |
| Novo Nordisk INC | $71.06 | 2023-2025 | Wegovy, Ozempic |
| Sanofi-Aventis U.S. LLC | $65.76 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $56.78 | 2024 | Arcalyst |
| Pfizer INC. | $50.30 | 2022-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $43.55 | 2025 | Amvuttra, Onpattro |
| Edwards Lifesciences Corporation | $40.32 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kestra Medical Technology Services, INC. | $35.18 | 2023-2024 | Assure Wcd |
| Genzyme Corporation | $28.36 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $21.53 | 2025 | Camzyos |
| Daiichi Sankyo INC. | $19.41 | 2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $16.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brielle Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.